Arvinas (ARVN) EBT Margin Growth (1y) (2018 - 2026)
Arvinas (ARVN) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - | - |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - | - |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn | 452.00 |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | 1,939.00 |
| 10 | Arvinas | 529.28 Mn | -85.62 Mn | - | -41,260.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,260.00 |
| Dec 31, 2025 | -63,051.00 |
| Sep 30, 2025 | -3,559.00 |
| Jun 30, 2025 | -22,880.00 |
| Mar 31, 2025 | 31,793.00 |
| Dec 31, 2024 | -43,231.00 |
| Sep 30, 2024 | 13,722.00 |
| Jun 30, 2024 | 7,462.00 |
| Mar 31, 2024 | -2,407.00 |
| Dec 31, 2023 | 53,879.00 |
| Sep 30, 2023 | -65.00 |
| Jun 30, 2023 | 6,928.00 |
| Mar 31, 2023 | -3,626.00 |
| Dec 31, 2022 | -4,448.00 |
| Sep 30, 2022 | 31,919.00 |
| Jun 30, 2022 | 72,490.00 |
| Mar 31, 2022 | 53,187.00 |
| Dec 31, 2021 | 48,770.00 |
| Sep 30, 2021 | -6,380.00 |
| Jun 30, 2021 | -42,384.00 |